[1] Bastola S,Pavlyukov MS,Yamashita D,et al.Glioma-initiating cells at tumor edge gain signals from tumor core cells to promote their malignancy[J].Nat Commun,2020,11(1):4660. [2] 黄琦,喻强,刘江,等.3.0T磁共振动态对比增强检查对脑胶质瘤分级诊断及其预后评估的价值[J].安徽医药,2021,25(9):1855~1858. [3] 国家卫生健康委员会医政医管局.脑胶质瘤诊疗规范(2018年版)[J].中华神经外科杂志,2019,35(3):217~239. [4] Jiang Q,Xie Q,Hu C,et al.Glioma malignancy is linked to interdependent and inverse AMOG and L1 adhesion molecule expression[J].BMC Cancer,2019,19(1):911. [5] 白庆岭,胡长伟,彭营影,等.脑胶质瘤预后影响因素分析[J].临床误诊误治,2018,31(7):97~100. [6] Di N,Yao C,Cheng W,et al.Correlation of dynamic contrast-enhanced MRI derived volume transfer constant with histological angiogenic markers in high-grade gliomas[J].J Med Imaging Radiat Oncol,2018,62(4):1954~1956. [7] Hilario A,Hernandez-Lain A,Sepulveda JM,et al.Perfusion MRI grading diffuse gliomas:Impact of permeability parameters on molecular biomarkers and survival.Neurocirugia,2019,30(1):11~18. [8] 吴静,汪文胜,颜刘清,等.rCBFmax值对胶质瘤术前分级的价值及与MVD表达间关系的初步研究[J].磁共振成像,2018,9(6):417~421. [9] 张华.磁共振成像在颅脑胶质瘤鉴别诊断临床价值分析[J].医学影像学杂志,2019,29(9):1450~1453. [10] 杨利民,范海霞,王景顺.MRI不同技术在脑胶质瘤术前分级中的应用价值[J].中国CT和MRI杂志,2018,16(6):60~62,84. [11] 陈邦荣.分析CT灌注成像在脑胶质瘤诊断中的应用价值[J].现代医用影像学,2018,27(8):88~89. [12] 梅东东,罗燕,龚静山,等.基于全肿瘤ADC图纹理特征诊断脑胶质瘤分级[J].中国医学影像技术,2019,35(7):976~980. [13] 王大堃,刘辉,董涛.DCE-MRI测量Ktrans值,Ve值联合ADC值与脑胶质瘤患者MVD及病理分期的相关性[J].中国临床医学影像杂志,2020,31(11):766~769. [14] 彭令荣,孔庆聪,江婷,等.脑胶质瘤的表观扩散系数值与其病理分级的相关性研究[J].中华神经医学杂志,2017,16(10):1041~1045. |